Safety and clinical activity of 1L atezolizumab + bevacizumab in a phase Ib study in hepatocellular carcinoma (HCC).Stacey Stein,Michael J. Pishvaian,Michael Sangmin Lee,Kyung-Hun Lee,Sairy Hernandez,Antonia Kwan,Bo Liu,William Grossman,Koho Iizuka,Baek-Yeol RyooJournal of Clinical Oncology(2018)引用 63|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要